MarketIQ Analyst Report for The Cooper Companies, Inc. Common Stock

6140 STONERIDGE MALL RD, STE 590, PLEASANTON, CA, US
COO

Last Updated: 12 Sep 2024

Executive Summary

The Cooper Companies, Inc. (COO) is a leading global medical device company specializing in ophthalmic products. The company's strong financial performance, solid fundamentals, and positive analyst sentiment make it an attractive investment opportunity.

Company Overview

CooperCompanies is headquartered in San Ramon, California, and has operations in over 100 countries. The company's core businesses include contact lenses, intraocular lenses (IOLs), and surgical instruments for ophthalmic procedures. CooperCompanies has a strong brand reputation and a history of innovation.

Fundamental Analysis

Revenue Growth: The company has consistently delivered revenue growth, with a 7.8% increase in the latest quarter year-over-year.
Profitability: CooperCompanies has strong profitability metrics, with a net income margin of 9.45%.
Valuation: The stock is currently trading at a trailing PE ratio of 60.28, which is above the industry average. However, the company's strong growth prospects and solid fundamentals justify the premium valuation.
Financial Health: The company has a strong balance sheet with low debt and ample liquidity.

Technical Analysis

Trend: The stock is currently in an uptrend, trading above its 50-day and 200-day moving averages.
Support and Resistance: The stock has strong support at $93.94 (200-day moving average) and resistance at $108.68 (52-week high).
Momentum Indicators: Momentum indicators, such as the RSI and MACD, are bullish, suggesting that the uptrend is likely to continue.

Short Term Outlook

In the short term, CooperCompanies is expected to continue its positive momentum. The company's strong fundamentals and favorable technical analysis suggest that the stock could reach its analyst target price of $113.01.

Long Term Outlook

The long-term outlook for CooperCompanies is also positive. The company's focus on innovation and its strong market position in the growing ophthalmic market should drive continued growth.

Analyst Recommendations

Analysts are overwhelmingly bullish on CooperCompanies. Six analysts have a "Strong Buy" rating, five have a "Buy" rating, and nine have a "Hold" rating. The consensus analyst target price is $113.01. Conclusion The Cooper Companies, Inc. is a well-established and financially sound company with a strong track record of growth. The company's positive fundamentals, favorable technical analysis, and strong analyst sentiment make it an attractive investment opportunity for both short-term and long-term investors.